New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
10:00 EDTALB, WPX, TSN, SBH, PFS, PCYC, MSTR, MTDR, MWE, LSTR, ONE, FGP, FDO, DCO, COST, COLM, BOH, AGNC, ZIONOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Albemarle (ALB) upgraded to Buy from Hold at Topeka... American Capital Agency (AGNC) upgraded to Buy from Hold at Wunderlich... Bank of Hawaii (BOH) upgraded to Buy from Neutral at DA Davidson... Columbia Sportswear (COLM) upgraded to Hold from Sell at McAdams Wright... Costco (COST) upgraded to Conviction Buy from Neutral at Goldman... Ducommun (DCO) upgraded to Buy from Neutral at DA Davidson... Family Dollar (FDO) upgraded to Neutral from Underweight at Piper Jaffray... Ferrellgas Partners LP (FGP) upgraded to Neutral from Sell at Citigroup... Higher One (ONE) upgraded to Overweight from Underweight at Piper Jaffray... Landstar System (LSTR) upgraded to Buy from Hold at BB&T... MarkWest Energy (MWE) upgraded to Buy from Hold at Wunderlich... Matador (MTDR) upgraded to Outperform from Market Perform at BMO Capital... MicroStrategy (MSTR) upgraded at JMP Securities... Pharmacyclics (PCYC) upgraded to Outperform from Market Perform at Leerink... Provident Financial (PFS) upgraded at Sterne Agee... Sally Beauty (SBH) upgraded to Buy from Neutral at Citigroup... Tyson Foods (TSN) upgraded to Buy from Hold at Miller Tabak... WPX Energy (WPX) upgraded to Accumulate from Hold at Tudor Pickering... Zions Bancorp (ZION) upgraded at Bernstein.
News For ALB;AGNC;BOH;COLM;COST;DCO;FDO;FGP;ONE;LSTR;MWE;MTDR;MSTR;PCYC;PFS;SBH;TSN;WPX;ZION From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 23, 2014
07:50 EDTLSTRLandstar System reports Q3 EPS 82c, consensus 81c
Subscribe for More Information
October 22, 2014
17:09 EDTALBAlbemarle reports Q3 adjusted EPS $1.14, consensus $1.02
Subscribe for More Information
16:27 EDTMWEMarkWest Energy raises FY14 DCF view to $680M-$700M
As a result of strong year-to-date operational and financial performance, the Partnership is increasing its 2014 DCF guidance to a range of $680M-$700M and 2014 Adjusted EBITDA to a range of $860M-$880M. Achieving the mid-point of these revised ranges would result in year-over-year DCF growth of 43 percent and year-over-year Adjusted EBITDA growth of 44%.
16:26 EDTMWEMarkWest Energy raises quarterly cash distribution to 89c from 85c per unit
Subscribe for More Information
15:30 EDTALBNotable companies reporting after market close
Subscribe for More Information
October 21, 2014
17:27 EDTFDOFamily Dollar certifies substantial compliance with FTC
Subscribe for More Information
October 20, 2014
16:13 EDTZIONZions Bancorp reports Q3 EPS 40c, consensus 44c
The estimated Tier 1 common equity ratio increased to 11.88% at September 30. Net loans and leases held for investment increased $110M to $39.7B. The allowance for credit losses was $690M. Tangible book value per share for Q3 was $26.00.
15:30 EDTZIONNotable companies reporting after market close
Subscribe for More Information
14:01 EDTCOSTCostco upgraded to Outperform from Peer Perform at Wolfe Research
Subscribe for More Information
08:31 EDTFDOFamily Dollar sets Oct. 30 as record date for special meeting of stockholders
Family Dollar Stores (FDO) announced that October 30, 2014 has been established as the record date for determining stockholders entitled to receive notice of, and to vote at, the Special Meeting of Stockholders, at which stockholders will be asked to adopt the previously announced merger agreement, as amended, with Dollar Tree (DLTR).
08:14 EDTPCYCPharmacyclics files supplmeental NDA for Imbruvica for macroglobulinemia
Pharmacyclics (PCYC) announced that it has submitted a supplemental New Drug Application to the FDA based on data from a Phase 2 study evaluating the use of IMBRUVICA in patients with Waldenstrom's macroglobulinemia. IMBRUVICA, which received FDA Breakthrough Therapy Designation in February 2013 for patients with WM, is being jointly developed and commercialized by Pharmacyclics and Janssen Biotech (JNJ).
06:21 EDTAGNCAmerican Capital downgraded to Market Perform from Outperform at JMP Securities
Subscribe for More Information
October 17, 2014
17:36 EDTFDOFamily Dollar says will review Elliot notice on directors in due course
Subscribe for More Information
17:11 EDTWPXIntegrated Core Strategies reports 4.6% passive stake in WPX Energy
Subscribe for More Information
16:09 EDTFDOElliott Advisors expresses concerns over Family Dollar merger, nominates slate
Subscribe for More Information
09:07 EDTTSNProtein stock pullback on Sanderson comments overdone, says BMO Capital
BMO Capital views yesterday's decline in Sanderson Farms (SAFM), Pilgrim's Pride (PPC) and Tyson Foods (TSN) as an overreaction to Sanderson's comments regarding breast prices falling to year-ago levels for the next four months. BMO notes that breast prices always dip in the fall. Following Sanderson's investor day, BMO said it sees a greater probability of chicken margins remaining at near-record levels in 2015. It keeps an Outperform rating on the stock.
08:57 EDTPCYCPharmacyclics price target raised to $188 from $185 at Roth Capital
Subscribe for More Information
08:51 EDTPCYCPharmacyclics announces European approval for Imbruvica
Subscribe for More Information
08:34 EDTPCYCPharmacyclics management to meet with JPMorgan
Subscribe for More Information
07:39 EDTTSNChicken stock sell-off yesterday overdone, says JPMorgan
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use